BioCentury | Sep 25, 2006
Company News

ChemBridge, AstraZeneca deal

...ChemBridge and its spin-off ChemBridge Research Laboratories Inc. will provide chemistry services to AZN for the discovery of small...
BioCentury | Jun 20, 2005
Company News

ChemBridge Research, Trimeris deal

...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge Research...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge Research...
BioCentury | May 9, 2005
Company News

ChemBridge Research, St. Jude Children's Research Hospital Inc. deal

...ChemBridge Research and the hospital extended their cancer deal under which ChemBridge Research is using medicinal chemistry...
...against targets identified by St. Jude. The targets are related to anaplastic lymphoma kinase (ALK). ChemBridge Research...
BioCentury | Jun 7, 2004
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...The payment was triggered by Eisai validating ChemBridge Research's preclinical compounds against an undisclosed GPCR target. ChemBridge Research...
BioCentury | Feb 16, 2004
Company News

ChemBridge, Merck KGaA, Pfizer deal

...The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC will...
...of the deal to include medicinal chemistry support for Pfizer Global Research and Development. Separately, ChemBridge Research...
BioCentury | Nov 17, 2003
Company News

ChemBridge Research Laboratories LLC, Memorial Sloan-Kettering Cancer Center deal

...Under a five-year deal, ChemBridge Research will provide its small molecule PHARMACophore, GPCR and Kinase targeted libraries...
...potential cancer therapeutics. ChemBridge also will provide access to various chemistry technologies for hit optimization. ChemBridge Research...
BioCentury | Dec 16, 2002
Company News

ChemBridge Research Laboratories LLC, Novartis deal

...Under a three-year discovery chemistry deal, ChemBridge Research will supply its GPCR-targeted library of small molecules based...
...institute will provide certain screening data to ChemBridge Research relating to the compounds in the library. ChemBridge Research...
BioCentury | Apr 8, 2002
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...identified by Eisai. ChemBridge Research will receive a technology access fee and is eligible for milestones. ChemBridge Research...
BioCentury | Apr 3, 2002
Company News

ChemBridge, Eisai discovery deal

...Japan) and support the chemical optimization of lead molecules identified by Eisai . In exchange, ChemBridge Research...
BioCentury | Jan 28, 2002
Company News

ChemBridge Corp., Pfizer deal

...Chembridge and its spin-off Chembridge Research Laboratories LLC (San Diego, Calif.) will design and develop combinatorial compound...
...and Chembridge Research will receive annual R&D funding, and PFE will make an equity investment in Chembridge Research...
Items per page:
1 - 10 of 15
BioCentury | Sep 25, 2006
Company News

ChemBridge, AstraZeneca deal

...ChemBridge and its spin-off ChemBridge Research Laboratories Inc. will provide chemistry services to AZN for the discovery of small...
BioCentury | Jun 20, 2005
Company News

ChemBridge Research, Trimeris deal

...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge Research...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge Research...
BioCentury | May 9, 2005
Company News

ChemBridge Research, St. Jude Children's Research Hospital Inc. deal

...ChemBridge Research and the hospital extended their cancer deal under which ChemBridge Research is using medicinal chemistry...
...against targets identified by St. Jude. The targets are related to anaplastic lymphoma kinase (ALK). ChemBridge Research...
BioCentury | Jun 7, 2004
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...The payment was triggered by Eisai validating ChemBridge Research's preclinical compounds against an undisclosed GPCR target. ChemBridge Research...
BioCentury | Feb 16, 2004
Company News

ChemBridge, Merck KGaA, Pfizer deal

...The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC will...
...of the deal to include medicinal chemistry support for Pfizer Global Research and Development. Separately, ChemBridge Research...
BioCentury | Nov 17, 2003
Company News

ChemBridge Research Laboratories LLC, Memorial Sloan-Kettering Cancer Center deal

...Under a five-year deal, ChemBridge Research will provide its small molecule PHARMACophore, GPCR and Kinase targeted libraries...
...potential cancer therapeutics. ChemBridge also will provide access to various chemistry technologies for hit optimization. ChemBridge Research...
BioCentury | Dec 16, 2002
Company News

ChemBridge Research Laboratories LLC, Novartis deal

...Under a three-year discovery chemistry deal, ChemBridge Research will supply its GPCR-targeted library of small molecules based...
...institute will provide certain screening data to ChemBridge Research relating to the compounds in the library. ChemBridge Research...
BioCentury | Apr 8, 2002
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...identified by Eisai. ChemBridge Research will receive a technology access fee and is eligible for milestones. ChemBridge Research...
BioCentury | Apr 3, 2002
Company News

ChemBridge, Eisai discovery deal

...Japan) and support the chemical optimization of lead molecules identified by Eisai . In exchange, ChemBridge Research...
BioCentury | Jan 28, 2002
Company News

ChemBridge Corp., Pfizer deal

...Chembridge and its spin-off Chembridge Research Laboratories LLC (San Diego, Calif.) will design and develop combinatorial compound...
...and Chembridge Research will receive annual R&D funding, and PFE will make an equity investment in Chembridge Research...
Items per page:
1 - 10 of 15